Macroagregados De Albúmina Humana Curium

Human albumin macroaggregates, the active ingredient in Macroagregados De Albúmina Humana Curium, is a plasma protein presented as a sterile solution for intravenous use. It is employed to increase plasma oncotic pressure and expand intravascular volume in patients with hypovolemia, shock, severe burns, or hypoalbuminemia. GNH USA supplies Macroagregados De Albúmina Humana Curium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Human albumin macroaggregates acts as a plasma volume expander in conditions of reduced circulating blood volume. - Hypovolemia: restores intravascular volume and improves tissue perfusion. - Shock: supports circulatory stability during acute circulatory failure. - Severe burns: compensates for protein loss and fluid shifts. - Hypoalbuminemia: raises serum albumin levels and oncotic pressure.

Human albumin macroaggregates may be associated with a range of adverse reactions.

Common Side Effects: - Fever or chills during infusion. - Transient hypotension or hypertension. - Mild allergic skin reactions such as rash or urticaria. - Headache or dizziness. - Nausea or vomiting. - Local infusion site irritation.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Pulmonary edema due to rapid volume overload. - Coagulopathy or bleeding abnormalities. - Acute renal impairment. - Thromboembolic events. - Severe electrolyte disturbances.

Human albumin macroaggregates should be used with careful clinical monitoring. - Volume status assessment: evaluate fluid balance before and during therapy. - Albumin level monitoring: check serum albumin to guide dosing. - Cardiac caution: avoid rapid infusion in patients with heart failure. - Hypersensitivity screening: contraindicated in known allergy to albumin products. - Co‑administration with diuretics: monitor electrolytes closely. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Human albumin macroaggregates can interact with other medications affecting fluid balance or coagulation.

Major Interactions (Avoid): - Concurrent use with other colloid volume expanders may cause fluid overload. - Simultaneous administration with high‑dose diuretics can precipitate severe electrolyte shifts. - Combination with ACE inhibitors in unstable patients may exacerbate hypotension.

Moderate Interactions (Monitor Closely): - Anticoagulants: monitor for altered bleeding risk. - Nephrotoxic agents: assess renal function regularly. - Corticosteroids: watch for enhanced fluid retention.